Publikationen von Vehreschild, J. J.

Rüthrich, Maria Madeleine, Giessen-Jung, C., Borgmann, S., Classen, A. Y., Dolff, S., Grüner, B., Hanses, F., Isberner, N., Köhler, P., Lanznaster, J., Merle, U., Nadalin, S., Piepel, C., Schneider, J., Schons, M., Strauss, R., Tometten, L., Vehreschild, J. J., von Lilienfeld-Toal, M., Beutel, G. und Wille, K. (2021) COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry. Annals of Hematology 100 (2), S. 383-393. Volltext nicht vorhanden.

Farowski, F., Els, G., Tsakmaklis, A., Higgins, P. G. , Kahlert, C. R. , Stein-Thoeringer, C. K., Bobardt, J. S., Dettmer-Wilde, Katja, Oefner, Peter J., Vehreschild, J. J. und Vehreschild, M. J. G. T. (2018) Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of Clostridiales. Gut Microbes, S. 1-9. Volltext nicht vorhanden.

Boch, T., Spiess, B., Cornely, O. A. , Vehreschild, J. J., Rath, P. M., Steinmann, J., Heinz, W. J., Hahn, J., Krause, S. W., Kiehl, M. G., Egerer, G., Liebregts, T., Koldehoff, M., Klein, M., Nolte, F., Mueller, M. C., Merker, N., Will, S., Mossner, M. , Popp, H., Hofmann, W.-K., Reinwald, M. und Buchheidt, D. (2016) Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study. Clinical Microbiology and Infection 22 (10), S. 862-868. Volltext nicht vorhanden.